This protocol addresses the management of alcohol-induced cardiomyopathy in the specific context of dilated cardiomyopathy accompanied by symptomatic heart failure and a persistently reduced left ventricular ejection fraction.
Clinical scenario: Dilated cardiomyopathy with symptomatic heart failure and a left ventricular ejection fraction of 35% or below that persists despite more than 3 months of optimal medical therapy.
When significant left ventricular dysfunction and heart failure symptoms persist despite an adequate course of optimised treatment, the focus shifts to reducing the risk of sudden cardiac death and all-cause mortality. A device-based intervention is part of the structured approach for this situation — the complete regimen is available via the link below.
Approach: Current evidence supports a specific device-based strategy in this setting to address sudden death risk. The full structured protocol, including the complete clinical pathway, is one click away.
An ICD should be considered to reduce the risk of sudden death and all-cause mortality in patients with DCM, symptomatic heart failure, and LVEF ≤35% despite >3 months of OMT.
DOI: 10.1093/eurheartj/ehad194
View source ↗